Showcases Stock ranks Forex

Novocure Ltd Ord Sh (NVCR)
126.84  10.16 (8.71%) 11-27 13:00
Open: 119.31 Pre. Close: 116.68
High: 127.58 Low: 119.05
Volume: 818,598 Market Cap: 12,912M
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and NovoTTF-100L, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients with glioblastoma. It is also developing products that are in Phase 2 pilot and Phase 3 pivotal trials for brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer, and mesothelioma. The company markets its products in the European Union, Japan, and internationally. It has a clinical trial collaboration agreement with MSD to evaluate tumor treating fields together with KEYTRUDA, an anti-PD-1 therapy; and a strategic alliance with the NYU Grossman School of Medicine's Department of Radiation Oncology that provides a framework for preclinical and clinical development projects studying Tumor Treating Fields. NovoCure Limited was founded in 2000 and is based in Saint Helier, Jersey.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 123.887 - 124.563 124.563 - 125.125
Low: 113.945 - 114.755 114.755 - 115.428
Close: 115.455 - 116.696 116.696 - 117.727
Stock Technical Analysis
Target: Six months: 160.55
One year: 187.53
Support: Support1: 119.65
Support2: 108.64
Resistance: Resistance1: 137.46
Resistance2: 160.55
Pivot: 123.99
Moving Averages: MA(5): 125.94
MA(20): 122.61
MA(100): 99.21
MA(250): 83.81
MACD: MACD(12,26): 1.23
Signal(12,26,9): 1.51
%K %D: %K(14,3): 24.24
%D(3): 41.75
RSI: RSI(14): 53.70
52-Week: High: 140.89
Low: 53.4
Change(%): 43.8
Average Vol(K): 3-Month: 121568
10-Days: 99027
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.

NVCR has closed below upper band by 34.7%. Bollinger Bands are 11.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Sat, 28 Nov 2020
Would I Choose Natera, Inc. (NASDAQ:NTRA) Stock at Any Point in Time? - Stocks Register

Sat, 28 Nov 2020
Is Surgalign Holdings, Inc. (NASDAQ:SRGA) Dead in the Water? - Stocks Register

Fri, 27 Nov 2020
Thinking Of Buying Co-Diagnostics, Inc. (NASDAQ:CODX) Stock? Read This First - Stocks Register

Fri, 27 Nov 2020
Looking for a Top Momentum Pick? Why XpresSpa Group, Inc. (NASDAQ:XSPA) is a Great Choice - Stocks Register

Thu, 26 Nov 2020
Is It Safe to Invest in Premier, Inc. (NASDAQ:PINC) Now? - Stocks Register

Wed, 25 Nov 2020
Should This Keep Teladoc Health, Inc. (NYSE:TDOC) Investors Up At Night? - Stocks Register

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Health Care Equipment & Services
Shares Out. (M) 101.80
Shares Float (M) 84.06
% Held by Insiders 16.42
% Held by Institutions 84.93
Shares Short (K) 4110
Shares Short Prior Month (K) 5330
Stock Financials
EPS 0.180
Book Value (p.s.) 3.020
Profit Margin 4.26
Operating Margin 4.18
Return on Assets (ttm) 2.7
Return on Equity (ttm) 7.7
Qtrly Rev. Growth 44.1
Gross Profit (p.s.) 2.584
Sales Per Share 4.417
EBITDA (p.s.) 0.258
Qtrly Earnings Growth 381.00
Operating Cash Flow (M) 52.63
Levered Free Cash Flow (M) 32.96
Stock Valuation
PE Ratio 704.67
PEG Ratio
Price to Book value 42.00
Price to Sales 28.72
Price to Cash Flow 245.34
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator